Cardiovascular Journal of Africa: Vol 35 No 3 (SEPTEMBER/OCTOBER 2024)

MORE CHOICE MORE SUSTAINED CONTROL1 For further product information contact PHARMA DYNAMICS Email info@pharmadynamics.co.za CUSTOMER CARE LINE +27 21 707 7000 www.pharmadynamics.co.za DYNACAZ 30, 60, 90 mg MR. Each tablet contains 30, 60, 90 mg gliclazide respectively. S3 A42/21.2/0249 , A48/21.2/1194, A53/21.2/0083. For full prescribing information, refer to the professional information approved by SAHPRA, 15 June 2021. 1) McGavin JK, et al. Gliclazide modified release. Drugs 2002;62(9):1357-1364. 2) Crepaldi G and Fioretto P. Gliclazide modified release: Its place in the therapeutic armamentarium. Metabolism 2000;49(10)supplement 2:21-25. DCZC1038/04/2024. A compelling choice in sulphonylurea treatment: 2 Once daily formulation Improved compliance UNIQUE SCORED 90 mgMR F O R M U L AT I O N MR GLICLAZIDE 60 mg 90 mg Dynacaz 30 mg

RkJQdWJsaXNoZXIy NDIzNzc=